Genetic Signatures Limited Price (GSS.AX)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

165,264,402

(12.5692)%

Genetic Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Genetic Signatures Limited operates as a molecular diagnostic (MDx) company in Australia, the Asia Pacific, the Americas, Europe, the Middle East, Israel, and Africa. It designs and manufactures a suite of real-time polymerase chain reaction-based products for detection of infectious diseases under the EasyScreen brand name. The company also provides MDx 3Base platform technology that enables hospital and pathology laboratories to screen for a range of infectious pathogens. In addition, it offers detection kits for gastrointestinal infections, respirator... Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $0.475-0.85
  • Market Cap 126.06M
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Medical - Diagnostics & Research

  • ceo: Ms. Allison Rossiter
  • IPO Date: March, 30, 2015
  • Country: AU
  • Currency: AUD
  • Headquaters: Newtown, NSW
  • Employees: No Data

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation